A comparative study of immunohistochemical and chromogenic in situ hybridization (CISH) evaluation of HER2 status in breast cancer

被引：0
|
作者：
Lubomirova, Hristova S. [1 ]
Vlahova, I. A. [1 ]
Iliichev, Dikov T. [1 ]
机构：
[1] Med Univ Sofia, Sofia, Bulgaria
来源：
VIRCHOWS ARCHIV | 2009年 / 455卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：192 / 192
页数：1
相关论文
共 50 条
  • [21] HER2 status in invasive breast cancer: Immunohistochemistry, fluorescence in-situ hybridization and chromogenic in-situ hybridization
    Shirsat, Hemlata S.
    Epari, Sridhar
    Shet, Tanuja
    Bagal, Rajani
    Hawaldar, Rohini
    Desai, Sangeeta B.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (02) : 175 - 179
  • [22] Automatic quantification of HER2 amplification in invasive breast cancer using chromogenic in situ hybridization (CISH) and computational pathology
    Hossain, M. S.
    Nakamura, T.
    Hanna, M.
    Uraoka, N.
    Ross, D. S.
    Hameed, R.
    Yamaguchi, M.
    Yagi, Y.
    VIRCHOWS ARCHIV, 2019, 475 : S18 - S18
  • [23] Comparison of chromogenic in situ hybridization with other methodologies for HER2 status assesment in breast cancer
    Cornelia Hauser-kronberger
    Nadia Dandachi
    Journal of Molecular Histology, 2004, 35 (6) : 647 - 653
  • [24] Comparison of chromogenic in situ hybridization with other methodologies for HER2 status assesment in breast cancer
    Hauser-Kronberger, C
    Dandachi, N
    JOURNAL OF MOLECULAR HISTOLOGY, 2004, 35 (06) : 647 - 653
  • [25] Performance of chromogenic in situ hybridization on testing HER2 status in breast carcinoma
    Bchir, A.
    Abdessayed, N.
    Ben Abdelkhader, A.
    Mokni, M.
    HISTOPATHOLOGY, 2022, 81 : 32 - 32
  • [26] Dual color chromogenic in situ hybridization for determination of HER2 status in breast cancer: a large comparative study to current state of the art fluorescence in situ hybridization
    Mollerup, Jens
    Henriksen, Ulla
    Mueller, Sven
    Schonau, Andreas
    BMC CLINICAL PATHOLOGY, 2012, 12
  • [27] Chromogenic in situ hybridization (CISH) to detect HER2 gene amplification in breast and gastric cancer: Comparison with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH)
    Kiyose, Shinichiro
    Igarashi, Hisaki
    Nagura, Kiyoko
    Kamo, Takaharu
    Kawane, Kazunori
    Mori, Hiroki
    Ozawa, Takachika
    Maeda, Matsuyoshi
    Konno, Keisuke
    Hoshino, Hideaki
    Konno, Hiroyuki
    Ogura, Hiroyuki
    Shinmura, Kazuya
    Hattori, Naohiko
    Sugimura, Haruhiko
    PATHOLOGY INTERNATIONAL, 2012, 62 (11) : 728 - 734
  • [28] HER2 amplification: Correlation of chromogenic in situ hybridization (CISH) with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH)
    Wixom, CR
    Albers, EA
    Weidner, N
    LABORATORY INVESTIGATION, 2003, 83 (01) : 51A - 51A
  • [29] HER2 amplification: Correlation of chromogenic in situ hybridization (CISH) with inummohistochemistry (IHC) and fluorescence in situ hybridization (FISH)
    Wixom, CR
    Albers, EA
    Weidner, N
    MODERN PATHOLOGY, 2003, 16 (01) : 51A - 51A
  • [30] HER2/neu Testing in Breast Carcinoma. Concordance Study Fluorescent In Situ Hybridization (FISH) vs. Chromogenic In Situ Hybridization (CISH)
    Elavathil, L.
    Dhesy, B.
    Wiernikowski, J.
    Browning, D.
    Akhtar-Danesh, N.
    Hanna, W.
    LABORATORY INVESTIGATION, 2009, 89 : 38A - 38A
12345